You are using an outdated browser. Please upgrade your browser to improve your experience.
cancerdata - new cancer drugs

The purpose of this app is to spread new knowledge in cancer by ranking new drugs and identifying links

The purpose of this app is to spread new knowledge in cancer by ranking new drugs and identifying links

cancerdata - new cancer drugs

by kim harford
cancerdata - new cancer drugs
cancerdata - new cancer drugs
cancerdata - new cancer drugs

What is it about?

The purpose of this app is to spread new knowledge in cancer by ranking new drugs and identifying links.

cancerdata - new cancer drugs

App Details

Version
2
Rating
NA
Size
34Mb
Genre
Medical Business
Last updated
December 23, 2017
Release date
May 25, 2016
More info

App Screenshots

cancerdata - new cancer drugs screenshot-0
cancerdata - new cancer drugs screenshot-1
cancerdata - new cancer drugs screenshot-2
cancerdata - new cancer drugs screenshot-3

App Store Description

The purpose of this app is to spread new knowledge in cancer by ranking new drugs and identifying links.

Rank new cancer drugs in trials
-by CANCER TYPE (e.g. lung cancer trial results)
-by COMPANY (e.g. new cancer drugs by Merck, BMS etc)
-by CATEGORY (e.g. anti PD1's, anti PDL1's, vaccines, combinations..)

You get a massive searchable database of oncology companies, drugs, combination drugs, cancer types and genetic analysis.

You can press SYNC to update your app with data and news.

Use the menu key top-left. Menus include:-

-Lung cancer drugs and advances,
-Colorectal cancer with mutation analysis,
-Lymphoma and liquid cancers,
-Other cancers such as breast, prostate, ovarian and melanoma,
-Non-cancer diseases,
-Companies A-Z,
-Nordic companies specialized view,
-Most interesting in cancer (Where we are, ASCO, ESMO highlights, viral links..)

Categories cover:-
-Immunotherapy drugs, CAR-T and T cell therapy.
-Oncolytic virus vaccines,
-Cancer stem cell agents and anti-Notch,
-Big data - Machine learning - Genetics - Electronics,
-Gene-editing and CRISPR,
-Biomarker targets,
-DNA repair drugs and parps,
-RNA interference agents and micro RNA agents,
-Bispecific antibodies,
-Bacteria agents
-Combinations

Categories cover inhibitors of:-
-4-1BB, Akt, AXL, B7, BTK, CCR4, CCR5, CDK, CD27, CTLA4, cytokines, epigenetic HDAC, FGF, GD2 antigen, glutaminase, heat shock proteins, HER, IDO, IDH2, KIR, LAG, MAGE, MEK, MET, microtubule dynamics, Myc, NY-ESO, Ox40, PAD, Parp, PD-1, PD-L1, PI3k, RAF, RAS, SLAMF7, Telomerase, TLR, TREG, VEGF, Wnt, XPO-1 and more.

Users include:-
-Oncology companies,
-Analysts & fund managers

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.